Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Bio-Rad Laboratories (NYSE:BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Bio-Rad Laboratories has a consensus price target of $334.25.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $364.42 last updated October 12, 2026 at 4:16 PM EDT.
There are no upcoming dividends for Bio-Rad Laboratories.
Bio-Rad Laboratories does not have any upcoming earnings scheduled.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.